Galaxy Laboratories Profile
Key Indicators
- Authorised Capital ₹ 12.00 Cr
- Paid Up Capital ₹ 7.32 Cr
- Company Age 33 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 26.70 Cr
- Satisfied Charges ₹ 19.18 Cr
- Revenue Growth -15.57%
- Profit Growth -23.41%
- Ebitda -28.46%
- Net Worth 14.33%
- Total Assets 5.45%
About Galaxy Laboratories
Galaxy Laboratories Private Limited (GLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 03 July 1991 and has a history of 33 years and seven months. Its registered office is in Aurangabad, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 7.32 Cr.
The company currently has active open charges totaling ₹26.70 Cr. The company has closed loans amounting to ₹19.18 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nagesh Walimbe and Shrikant Ramchandra serve as directors at the Company.
Company Details
-
Location
Aurangabad, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85190MH1991PTC062334
-
Company No.
062334
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Jul 1991
-
Date of AGM
10 Jun 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Galaxy Laboratories Private Limited offer?
Galaxy Laboratories Private Limited offers a wide range of products and services, including Organic and Inorganic Solvents, Alcohol Solvents.
Who are the key members and board of directors at Galaxy Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nagesh Walimbe
|
Director | 30-Sep-2002 | Current |
|
Shrikant Ramchandra
|
Director | 03-Jul-1991 | Current |
Financial Performance of Galaxy Laboratories.
Galaxy Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.57% decrease. The company also saw a substantial fall in profitability, with a 23.41% decrease in profit. The company's net worth Soared by an impressive increase of 14.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Galaxy Laboratories?
In 2023, Galaxy Laboratories had a promoter holding of 63.91% and a public holding of 36.09%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Paradigm Services Private LimitedNagesh Walimbe is a mutual person
-
Zen Adsorptions Private LimitedNagesh Walimbe is a mutual person
-
Organozen Chemicals Private LimitedNagesh Walimbe is a mutual person
-
Zen Chemiconsultech Private Limited
Nagesh Walimbe is a mutual person
-
Zen Distillation Technologies Private Limited
Nagesh Walimbe is a mutual person
-
Byk Yog Adhyatmik Forum
Shrikant Ramchandra is a mutual person
Charges (Loans)
₹26.70 Cr
₹19.18 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 15.62 Cr
- Others : 11.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Aug 2024 | Axis Bank Limited | ₹1.80 M | Open |
| 09 May 2024 | Axis Bank Limited | ₹4.75 Cr | Open |
| 03 Apr 2023 | Axis Bank Limited | ₹4.95 Cr | Open |
| 08 Dec 2022 | Axis Bank Limited | ₹1.80 M | Open |
| 26 Sep 2022 | Others | ₹3.60 M | Open |
How Many Employees Work at Galaxy Laboratories?
Unlock and access historical data on people associated with Galaxy Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Galaxy Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Galaxy Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
